Physical and Cognitive Effects of Fluoroscopy

NCT04689373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2022-02-01

No results posted yet for this study

Summary

Background and objectives:

The researchers will perform this study to reveal the clinical meaning of fatigue, headache, diarrhea, and impaired cognitive functions that are often expressed verbally in healthcare professionals who are exposed to fluoroscopy.

Methods:

After obtaining written informed consent, 84 samples will be included in the study. For operating room employees who meet the criteria determined before and after the operation; mini-mental state examination, weight, heart rate, non-invasive blood pressure value, VAS score for headache, radiation exposure time on fluoroscopy device, Rad measurement with the help of personal dosimeter before and after surgery, and total time in the operating room will be recorded.

Conditions

Interventions

DIAGNOSTIC_TEST

VAS Score

The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain. The Mini-Mental State Exam (MMSE) is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Nur Canbolat, MD · Istanbul University Faculty of Medicine Department of Anesthesiology

  • Elif Aygün, MD · Istanbul University Faculty of Medicine Department of Anesthesiology

  • Cansu Uzunturk, MD · Istanbul University Faculty of Medicine Department of Anesthesiology

  • Evren Aygun, MD · Istanbul University Faculty of Medicine Department of Anesthesiology

  • Yavuz Saglam, MD · Istanbul University Faculty of Medicine Department of Orthopedics

  • Mehmet I Buget, Assoc. Prof. · Istanbul University Faculty of Medicine Department of Anesthesiology

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-01-21
Completion
2022-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689373 on ClinicalTrials.gov